Timing of venous thromboembolism chemoprophylaxis using objective hemoglobin criteria in blunt solid organ injury

Injury. 2023 May;54(5):1356-1361. doi: 10.1016/j.injury.2022.12.017. Epub 2022 Dec 16.

Abstract

Background: The purpose of this study was to evaluate the safety and efficacy of early venous thromboembolism (VTE) chemoprophylaxis following blunt solid organ injury.

Methods: A retrospective review of patients was performed for patients with blunt solid organ injury between 2009-2019. Enoxaparin was initiated when patients had <1g/dl Hemoglobin decline over a 24 h period. These patients were then categorized by initiation: ≤48 h and >48 h.

Results: There were 653 patients: 328 (50.2%) <48 h and 325 (49.8%) ≥48 h. Twenty-nine (4.4%) developed VTE. Patients in ≥48 h group suffered more frequent VTE events (6.5% vs 2.4%, p = 0.021). Non-operative failure occurred in 6 patients (1.9%) in ≥48 h group, and 5 patients (1.5%) < 48 h group. Blood transfusion following chemophrophylaxis initiation was required in 69 (21.3%) in ≥48 h group, and 46 (14.0%) in < 48 h group, occurring similarly between groups (p=0.021).

Conclusion: Stable hemoglobin in the first 24 h is an efficacious, objective measure that allows early initiation of VTE chemoprophylaxis in solid organ injury. This practice is associated with earlier initiation of and fewer VTE events.

Keywords: Chemoprophylaxis; Deep vein thrombosis; Pulmonary embolism; Solid organ injury; Trauma; Venous thromboembolism.

MeSH terms

  • Anticoagulants / therapeutic use
  • Chemoprevention
  • Enoxaparin / therapeutic use
  • Humans
  • Retrospective Studies
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / prevention & control
  • Wounds, Nonpenetrating* / complications
  • Wounds, Nonpenetrating* / drug therapy

Substances

  • Anticoagulants
  • Enoxaparin